Brief: Glenmark Pharma Settles With United Healthcare For $11 Million
14/11/2025 10:33
Nov 14 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: GLENMARK PHARMA - SETTLES WITH UNITED HEALTHCARE FOR $11 MILLION GLENMARK PHARMA - DENIES ALL ALLEGATIONS IN SETTLEMENT GLENMARK PHARMA - GENERIC ZETIA AND VYTORIN ANTITRUST AND CONSUMER PROTECTION LITIGATIONS ARE NOW FULLY RESOLVED Source text: ID:nBSE1QZQkd Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter